| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2023-02-21 17:15:09 UTC |
|---|
| HMDB ID | HMDB0000759 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glycylleucine |
|---|
| Description | Glycylleucine, also known as GL or leucylglycine, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Glycylleucine has been detected, but not quantified in, several different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), domestic pigs (Sus scrofa domestica), and milk (cow). This could make glycylleucine a potential biomarker for the consumption of these foods. Glycylleucine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Glycylleucine. |
|---|
| Structure | CC(C)C[C@H](NC(=O)CN)C(O)=O InChI=1S/C8H16N2O3/c1-5(2)3-6(8(12)13)10-7(11)4-9/h5-6H,3-4,9H2,1-2H3,(H,10,11)(H,12,13)/t6-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| G-L | ChEBI | | GL | ChEBI | | Gly-L-leu | ChEBI | | Glycyl-L-leucine | ChEBI | | Glycyl-leucine | HMDB | | N-Glycyl-L-leucine | HMDB | | Leucylglycine | HMDB | | Leu-gly | HMDB | | Glycylleucine, (D)-isomer | HMDB | | Gly-leu | HMDB | | g-L Dipeptide | HMDB | | GL Dipeptide | HMDB | | Glycine leucine dipeptide | HMDB | | Glycine-leucine dipeptide | HMDB | | N-Glycylleucine | HMDB | | NSC 83257 | HMDB | | Glycylleucine | ChEBI |
|
|---|
| Chemical Formula | C8H16N2O3 |
|---|
| Average Molecular Weight | 188.2242 |
|---|
| Monoisotopic Molecular Weight | 188.116092388 |
|---|
| IUPAC Name | (2S)-2-(2-aminoacetamido)-4-methylpentanoic acid |
|---|
| Traditional Name | glycyl-L-leucine |
|---|
| CAS Registry Number | 869-19-2 |
|---|
| SMILES | CC(C)C[C@H](NC(=O)CN)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C8H16N2O3/c1-5(2)3-6(8(12)13)10-7(11)4-9/h5-6H,3-4,9H2,1-2H3,(H,10,11)(H,12,13)/t6-/m0/s1 |
|---|
| InChI Key | DKEXFJVMVGETOO-LURJTMIESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Peptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha peptide
- Leucine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Fatty acid
- Amino acid or derivatives
- Amino acid
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic oxide
- Organic oxygen compound
- Primary aliphatic amine
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Primary amine
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 233 - 235 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.4 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8892 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.73 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 265.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 856.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 257.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 82.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 59.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 283.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 282.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 535.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 626.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 228.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 923.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 175.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 206.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 416.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 379.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 165.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glycylleucine,1TMS,isomer #1 | CC(C)C[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C | 1657.7 | Semi standard non polar | 33892256 | | Glycylleucine,1TMS,isomer #2 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O | 1724.9 | Semi standard non polar | 33892256 | | Glycylleucine,1TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C | 1663.0 | Semi standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1769.7 | Semi standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1720.6 | Standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2264.2 | Standard polar | 33892256 | | Glycylleucine,2TMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1662.6 | Semi standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 1698.8 | Standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN)[Si](C)(C)C | 2453.7 | Standard polar | 33892256 | | Glycylleucine,2TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1758.9 | Semi standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1776.0 | Standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 2242.8 | Standard polar | 33892256 | | Glycylleucine,2TMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1899.6 | Semi standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1819.0 | Standard non polar | 33892256 | | Glycylleucine,2TMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2428.7 | Standard polar | 33892256 | | Glycylleucine,3TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1768.1 | Semi standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1835.3 | Standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C | 1978.6 | Standard polar | 33892256 | | Glycylleucine,3TMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1913.9 | Semi standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1887.3 | Standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2097.0 | Standard polar | 33892256 | | Glycylleucine,3TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1900.9 | Semi standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1924.1 | Standard non polar | 33892256 | | Glycylleucine,3TMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2145.7 | Standard polar | 33892256 | | Glycylleucine,4TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1949.7 | Semi standard non polar | 33892256 | | Glycylleucine,4TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1978.5 | Standard non polar | 33892256 | | Glycylleucine,4TMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1907.2 | Standard polar | 33892256 | | Glycylleucine,1TBDMS,isomer #1 | CC(C)C[C@H](NC(=O)CN)C(=O)O[Si](C)(C)C(C)(C)C | 1910.0 | Semi standard non polar | 33892256 | | Glycylleucine,1TBDMS,isomer #2 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O | 1956.1 | Semi standard non polar | 33892256 | | Glycylleucine,1TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 1898.5 | Semi standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2189.7 | Semi standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2130.7 | Standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #1 | CC(C)C[C@H](NC(=O)CN[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2389.4 | Standard polar | 33892256 | | Glycylleucine,2TBDMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2122.8 | Semi standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2082.7 | Standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #2 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN)[Si](C)(C)C(C)(C)C | 2524.5 | Standard polar | 33892256 | | Glycylleucine,2TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2216.7 | Semi standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2153.6 | Standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2392.6 | Standard polar | 33892256 | | Glycylleucine,2TBDMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2323.5 | Semi standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2176.8 | Standard non polar | 33892256 | | Glycylleucine,2TBDMS,isomer #4 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2505.1 | Standard polar | 33892256 | | Glycylleucine,3TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2436.9 | Semi standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2395.1 | Standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2355.5 | Standard polar | 33892256 | | Glycylleucine,3TBDMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2559.4 | Semi standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2434.0 | Standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #2 | CC(C)C[C@H](NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2394.7 | Standard polar | 33892256 | | Glycylleucine,3TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2559.2 | Semi standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2455.2 | Standard non polar | 33892256 | | Glycylleucine,3TBDMS,isomer #3 | CC(C)C[C@@H](C(=O)O)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2436.6 | Standard polar | 33892256 | | Glycylleucine,4TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2786.3 | Semi standard non polar | 33892256 | | Glycylleucine,4TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2687.4 | Standard non polar | 33892256 | | Glycylleucine,4TBDMS,isomer #1 | CC(C)C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2388.5 | Standard polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | Periodontal Probing Depth |
|---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
|
|
|---|
| General References | - Thompson JA, Markey SP, Fennessey PV: Gas-chromatographic/mass-spectrometric identification and quantitation of tetronic and deoxytetronic acids in urine from normal adults and neonates. Clin Chem. 1975 Dec;21(13):1892-8. [PubMed:1192581 ]
- Smirnov KV, Syrykh GD, Legen'kov VI, Goland-Ruvinova LG, Medkova IL: [Digestive system status after prolonged space flights]. Kosm Biol Aviakosm Med. 1982 Mar-Apr;16(2):19-22. [PubMed:7070032 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|